Beta Bionics, Inc. (BBNX)
17.71
+0.87
(+5.17%)
USD |
NASDAQ |
Oct 20, 16:00
17.71
0.00 (0.00%)
After-Hours: 20:00
Beta Bionics Total Liabilities (Quarterly) : 36.02M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 36.02M |
| March 31, 2026 | 33.17M |
| December 31, 2025 | 41.13M |
| September 30, 2025 | 35.29M |
| June 30, 2025 | 28.34M |
| March 31, 2025 | 24.27M |
| Date | Value |
|---|---|
| December 31, 2024 | 73.63M |
| September 30, 2024 | 64.07M |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | 51.43M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Edwards Lifesciences Corp. | 3.142B |
| Intuitive Surgical, Inc. | 2.579B |
| Stryker Corp. | 23.94B |
| Zimmer Biomet Holdings, Inc. | 10.17B |
| Inspire Medical Systems, Inc. | 100.41M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 292.39M |
| Shareholders Equity (Quarterly) | 256.37M |
| Debt to Equity Ratio | 0.0254 |
| Current Ratio | 8.880 |
| Net Debt Paydown Yield | 0.01% |